Ernexa Therapeutics Inc. (ERNA) Debt Ratio (2013 - 2026)
Ernexa Therapeutics' (ERNA) quarterly Debt Ratio came in at 0.0 in Q1 2026, down 44.66% on a QoQ basis from 0.01 in Q4 2025.
Ernexa Therapeutics Inc. (ERNA) Debt Ratio (2013 - 2026) Analysis & Trends
Ernexa Therapeutics (ERNA) has 13 years of Debt Ratio data on file, last reported at 0.0 in Q1 2026.
- Quarterly Debt Ratio changed N/A year-over-year to 0.0 in Q1 2026, while the trailing twelve-month figure through Mar 2026 was 0.0 (changed N/A YoY) and the FY2025 annual result came in at 0.01, changed N/A from the prior year.
- Debt Ratio eased to 0.0 in Q1 2026, from 0.01 in the prior quarter.
- In the past five years, Debt Ratio ranged from a high of 0.17 in Q1 2023 to a low of 0.0 in Q1 2026.
- A 4-year average of 0.05 and a median of 0.01 in 2025 frame the typical range for Debt Ratio.
Powered by 
Peer Comparison
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 0.00 |
| Dec 31, 2025 | 0.01 |
| Sep 30, 2025 | 0.01 |
| Jun 30, 2025 | 0.01 |
| Mar 31, 2023 | 0.17 |
| Dec 31, 2022 | 0.13 |
| Sep 30, 2021 | 0.01 |
| Jun 30, 2021 | 0.01 |
| Mar 31, 2021 | 0.02 |
| Dec 31, 2020 | 0.07 |
| Sep 30, 2020 | 0.66 |
| Mar 31, 2020 | 0.18 |
| Dec 31, 2019 | 0.39 |
| Sep 30, 2019 | 0.20 |
| Jun 30, 2019 | 0.21 |
| Mar 31, 2019 | 0.21 |
| Dec 31, 2018 | 0.21 |
| Jun 30, 2018 | 0.29 |
| Mar 31, 2018 | 0.31 |
| Dec 31, 2017 | 0.31 |